Projects per year
Personal profile
Education
- 2001.08-2005.08 Ph.D. Department of Food Science and Biotechnology, National Chung Hsing University
- 2006.01-2010.01 Post-Doctoral Fellow, National Institute of Cancer Research (National Health Research Institutes)
Experience
- 2010.04- Assistant Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
- 2014.02- Research Fellow and Executive Secretary, Taipei Medical University-Shuang Ho Hospital
Awards
- Chi-Tai Yeh received his Ph.D. in Food Science and Biotechnology from National Chung Hsing University. Dr. Yeh is currently the Research Fellow and Executive Secretary of Department of Research of Taipei Medical University-Shuang Ho Hospital. Dr. Yeh has contributed 2 book chapters, published 46 articles in the field of cancer & nutritional chemistry journal, and got 2 patents in the medical compound of cancer therapy. His major research interests include in cancer cell biology, cancer stem cell research, nutrigenomis and cancer chemoprevention with dietary phytochemicals.
Research Interests
- Cancer cell biology
- Cancer stem cell research
- Nutrigenomis and cancer chemoprevention with dietary phytochemicals
Fingerprint
Dive into the research topics where Chi-Tai Yeh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Navigating Dipeptidase 1 Dpep1'S Impact on Temozolomide-Tolerant Persister Glioblastoma: Mechanistic Insights and Treatment Innovations
Yeh, C.-T. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Investigation of the Mechanism of Action and Clinical Significance of a Newly Discovered Protein Phosphatase 1 Regulatory Subunit, Pp1r15b, in Drug Tolerant Persister Glioma Cells
Yeh, C.-T. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
研究 NUP210 及其醣化修飾調控 MYCN 基因擴增神經母細胞瘤幹細胞功能及抗藥性之作用
Yeh, C.-T. (PI)
1/1/22 → 12/31/22
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Study of Expression and Functional Mechanisms of Histone 3 K4 Demethylase JARID1B in Tumorigenesis and Correlation with Progression in Lung Cancer
Kuo, K.-T. (PI), Wang, L.-S. (CoI) & Yeh, C.-T. (CoI)
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
-
The Translational Characterization of the Role of Wnt/Beta-Catenin/Tcf Signaling in the Generation of Invasive and Chemoresistant Cancer Stem Population in Liver Cancer
Lee, W.-H. (PI) & Yeh, C.-T. (CoI)
8/1/11 → 7/31/12
Project: A - Government Institution › b - National Science and Technology Council
-
Generation and characterization of three induced pluripotent stem cell lines for modeling coronary artery vasospasm
Ross Tacco, I., Olshausen, J., Chan, T. Y., Turbes, N., Hung, M. Y., Yeh, C. T., Nguyen, P. K., Sallam, K., Sayed, N. & Chen, I. Y., Feb 2025, In: Stem Cell Research. 82, 103644.Research output: Contribution to journal › Article › peer-review
Open Access -
Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH-MYCN transgenic mice
Liao, Y. T., Yu, Z. K., Huang, Y. X., Lin, K. H., Kuo, C. T., Yang, T. S., Wu, P. Y., Yeh, C. T., Liu, Y. L., Chen, C. C., Chen, C. N., Hsu, W. M. & Lee, H., 2025, (Accepted/In press) In: Bioengineering and Translational Medicine.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells
Cheng, Y. C., Chen, M. Y., Yadav, V. K., Pikatan, N. W., Fong, I. H., Kuo, K. T., Yeh, C. T. & Tsai, J. T., Mar 2025, In: Translational Oncology. 53, 102274.Research output: Contribution to journal › Article › peer-review
Open Access -
Effects of statins in patients with coronary artery spasm: A nationwide population-based study
Lee, Y. C., Hung, M. J., Chen, T. H., Mao, C. T., Yeh, C. T., Kounis, N. G., Chen, I. Y., Hu, P. & Hung, M. Y., Nov 2024, In: Clinical and Translational Science. 17, 11, e70087.Research output: Contribution to journal › Article › peer-review
Open Access -
Notopterol mitigates IL-1β-triggered pyroptosis by blocking NLRP3 inflammasome via the JAK2/NF-kB/hsa-miR-4282 route in osteoarthritis
Chen, K. T., Yeh, C. T., Yadav, V. K., Pikatan, N. W., Fong, I. H., Lee, W. H. & Chiu, Y. S., Mar 30 2024, In: Heliyon. 10, 6, e28094.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)
Datasets
-
Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction
Huang, J.-S. (Contributor), Yao, C.-J. (Contributor), Chuang, S.-E. (Contributor), Yeh, C.-T. (Contributor), Lee, L.-M. (Creator), Chen, R.-M. (Contributor), Chao, W.-J. (Contributor), Whang-Peng, J. (Creator) & Lai, G.-M. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3643112.v1, https://figshare.com/collections/Honokiol_inhibits_sphere_formation_and_xenograft_growth_of_oral_cancer_side_population_cells_accompanied_with_JAK_STAT_signaling_pathway_suppression_and_apoptosis_induction/3643112/1
Dataset
-
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K.-T. (Contributor), Huang, W.-C. (Contributor), Bamodu, O. A. (Contributor), Lee, W.-H. (Contributor), Wang, C.-H. (Creator), Hsiao, M. (Contributor), Wang, L.-S. (Creator) & Yeh, C.-T. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4194263.v1, https://figshare.com/collections/Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/4194263/1
Dataset
-
Additional file 1: Table S1. of Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
Bamodu, O. A. (Contributor), Lee, W.-H. (Contributor), Chao, T.-Y. (Contributor), Huang, W.-C. (Contributor), Yeh, C.-T. (Contributor), Wu, A. (Creator), Hsiao, M. (Creator) & Wang, L. S. (Creator), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3621719_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3621719_d1.v1
Dataset
-
Additional file 3: Figure S2. of Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
Hsiao, M. (Creator), Yeh, C.-T. (Contributor), Wu, A. (Creator), Wang, L. S. (Creator), Bamodu, O. A. (Contributor), Lee, W.-H. (Contributor), Chao, T.-Y. (Contributor) & Huang, W.-C. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3621719_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3621719_d2.v1
Dataset
-
Additional file 2: Figure S1. of Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
Yeh, C.-T. (Contributor), Huang, W.-C. (Contributor), Wu, A. (Creator), Bamodu, O. A. (Contributor), Lee, W.-H. (Contributor), Wang, L. S. (Creator), Chao, T.-Y. (Contributor) & Hsiao, M. (Creator), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3621719_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3621719_d3.v1
Dataset